# Alex Vamvakas

> Alex Vamvakas is a seed investor at Evercurious VC backing Medical Device and Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Evercurious VC](https://shizune.co/investors/profile/evercurious-vc)
- Total investments: 5
- Last investment: Jun 2025
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/avamvakas/

Alex Vamvakas is a seed investor at Evercurious VC focused on Medical Device and Health Care. Alex Vamvakas - Partner @ Evercurious VC

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.2M–$4.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 4 | 80% |
| Health Care | 3 | 60% |
| Software | 2 | 40% |
| Virtual Reality | 2 | 40% |
| Medical | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 60% |
| Pre-Seed | 1 | 20% |
| Series B | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 2 | 40% |
| Sweden | 1 | 20% |
| Belgium | 1 | 20% |
| United Kingdom | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Koios Care | Koios Care is a startup in the field of digital health. Their objective is to develop innovative and validated digital daily activity biomarkers in order to improve care while lowering costs. | $1.2M | Seed | Jun 16, 2025 |  |
| Acorai | Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product, The Acorai Heart Monitor, can monitor mean pulmonary artery pressure (mPAP) non-invasively through a machine learning analysis of pressure dynamics in acoustics,vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. With a team with more than 50 years of industry experience, we can help heart failure patients live longer, healthier, and less uncertain lives.Acorai was founded in 2019 and is headquartered in Skane, Sweden. | $4.5M | Seed | Jan 19, 2024 |  |
| Neurovirt | Immersive Virtual Reality for gamification and quantification of movement rehabilitation |  | Pre-Seed | Jan 09, 2024 |  |
| Positrigo | Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. | $5.5M | Series B | Oct 24, 2022 |  |
| ORamaVR | ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality. |  | Seed |  |  |

5 of 5 investments shown.

## Co-investors
- [4FOX Ventures](https://shizune.co/investors/profile/4fo-ventures) — VC Fund, 1 deal together
- [Astylab Ventures](https://shizune.co/investors/profile/astylab-ventures) — VC Fund, 1 deal together
- [Carma Fund](https://shizune.co/investors/profile/carma-fund) — VC Fund, 1 deal together
- [CerraCap Ventures](https://shizune.co/investors/profile/cerracap-ventures) — VC Fund, 1 deal together
- [ETH Zurich Foundation](https://shizune.co/investors/profile/eth-zurich-foundation) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 1 deal together

## About Evercurious VC

VC Fund

Early stage deep-tech VC firm

2 contacts available at Evercurious VC.

| Name | Title | Profile |
| --- | --- | --- |
| Alex Vamvakas | Partner | https://shizune.co/investors/profile/alex-vamvakas |
| George Georgiadis | Partner | https://shizune.co/investors/profile/george-georgiadis-3bba |

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors in United Kingdom](https://shizune.co/investors/medical-device-angel-investors-united-kingdom)
- [Medical Device Angel Investors in Sweden](https://shizune.co/investors/medical-device-angel-investors-sweden)

## FAQ

### What does Alex Vamvakas invest in?

Alex Vamvakas invests primarily in Medical Device, Health Care and Software startups, most often at Seed and Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Alex Vamvakas's check size?

Alex Vamvakas typically joins rounds of $1.2M–$4.5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Alex Vamvakas participates in.

### When did Alex Vamvakas last invest?

The most recent investment recorded for Alex Vamvakas closed in Jun 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co